Management of neovascular age-related macular degeneration in clinical practice: initiation, maintenance, and discontinuation of therapy.

J Ophthalmol · 2011 · PMC3228281 · PMID 22174995

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

an interim analysis from the SAILOR study showed a trend for an increase in the incidence of stroke in the group treated with 0.5 mg of ranibizumab [ 47 , 48 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.